Health claims: Let science prevail

Annals of Nutrition and Metabolism

Volumn 58, Issue 1, 2011, Pages 79-81

  Koletzko, Berthold ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FATTY ACID; OMEGA 3 FATTY ACID;

ADOPTION; ARTIFICIAL MILK; BLOOD PRESSURE; FAMILY; FOOD SAFETY; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HUMAN; INFANCY; INFANT FEEDING; NOTE; NUTRITION; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; TOTAL QUALITY MANAGEMENT; VALIDITY; VISION; WEANING;

DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EUROPEAN UNION; HEALTH PROMOTION; HUMANS; INFANT FOOD; LEGISLATION, FOOD; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 79953218798     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327613     Document Type: Note

References (11)

1. Willmott G, Sarbu D, Childers N, Kadenbach K: Motion for a resolution pursuant to Rule 88(2) of the Rules of Procedure by Glenis Willmott, Daciana Sarbu, Nessa Childers and Karin Kadenbach on the draft commission regulation on the authorisation and refusal of authorisation of certain health claims made on foods and referring to children's development and health. European Parliament, Committee on the Environment, Public Health and Food Safety, Plenary Sitting 2011, B7 0000/2011.
2. EC Regulation No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union, 2007, L 12/3 (18.1.2007).
3. EFSA: Scientific opinion. DHA and ARA and visual development. Scientific substantiation of a health claim related to do cosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development pursuant to Article 14 of EC Regulation No 1924/20061. Scientific opinion of the Panel on Dietetic Products, Nutrition and Allergies (question No EFSAQ- 2008-211). Adopted on 22 January 2009. EFSA J 2009; 941: 1-14.
4. Simmer K, Patole SK, Rao SC: Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008:CD000376.
5. Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow- on formulae and amending Directive 1999/21/EC. Official Journal of the European Union, 2006, L 401/1 (30.12.2006).
6. Scientific Committee on Food EC, Koletzko B, Saris W, Flynn A, Palou A, Wal JM, Hernell O, Jackson A, Przyrembel H, Turck D: Report of the Scientific Committee on Food on the revision of essential requirements of infant formulae and follow-on formulae. Brussels, European Commission, 2003.
7. Kennedy K, Ross S, Isaacs EB, Weaver LT, Singhal A, Lucas A, et al: The 10-year followup of a randomised trial of long-chain polyunsaturated fatty acid supplementation in preterm infants: effects on growth and blood pressure. Arch Dis Child 2010; 95: 588-595.
8. Makrides M, Gibson RA, Udell T, Ried K: Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 2005; 81: 1094-1101. (Pubitemid 41724951)
9. Forsyth JS, Willatts P, Agostoni C, Bissenden J, Casaer P, Boehm G: Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial. BMJ 2003; 326: 953.
10. Agostoni C, Braegger C, Decsi T, Kolacek S, Koletzko B, Michaelsen KF, et al: Breastfeeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2009; 49: 112-125.
11. Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, Hernell O, et al: Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr 2005; 41: 584-599. (Pubitemid 41579668)